IMCIVREE

setmelanotide · Rhythm Pharmaceuticals, Inc

Drug timelines are a Plus or Pro feature.

15 regulatory and trial events tracked for IMCIVREE, covering 2016-02-22 to 2026-04-07. Get the full timeline:

Most recent: EMA Authorised: Imcivree (setmelanotide) — Rhythm Pharmaceuticals Netherlands B.V.